DE69737969D1 - Dns-impfung zur einleitung einer suppressiven t-zell-antwort - Google Patents

Dns-impfung zur einleitung einer suppressiven t-zell-antwort

Info

Publication number
DE69737969D1
DE69737969D1 DE69737969T DE69737969T DE69737969D1 DE 69737969 D1 DE69737969 D1 DE 69737969D1 DE 69737969 T DE69737969 T DE 69737969T DE 69737969 T DE69737969 T DE 69737969T DE 69737969 D1 DE69737969 D1 DE 69737969D1
Authority
DE
Germany
Prior art keywords
vaccination
suppressive
variable region
cell response
introduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69737969T
Other languages
English (en)
Other versions
DE69737969T2 (de
Inventor
Lawrence Steinman
Ari Waisman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Application granted granted Critical
Publication of DE69737969D1 publication Critical patent/DE69737969D1/de
Publication of DE69737969T2 publication Critical patent/DE69737969T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69737969T 1996-02-26 1997-02-24 Dns-impfung zur einleitung einer suppressiven t-zell-antwort Expired - Fee Related DE69737969T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/606,639 US5939400A (en) 1996-02-26 1996-02-26 DNA vaccination for induction of suppressive T cell response
US606639 1996-02-26
PCT/US1997/002837 WO1997030587A1 (en) 1996-02-26 1997-02-24 Dna vaccination for induction of suppressive t cell response

Publications (2)

Publication Number Publication Date
DE69737969D1 true DE69737969D1 (de) 2007-09-13
DE69737969T2 DE69737969T2 (de) 2008-04-24

Family

ID=24428824

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69737969T Expired - Fee Related DE69737969T2 (de) 1996-02-26 1997-02-24 Dns-impfung zur einleitung einer suppressiven t-zell-antwort

Country Status (8)

Country Link
US (1) US5939400A (de)
EP (1) EP0884947B1 (de)
JP (1) JP2000506130A (de)
AT (1) ATE368378T1 (de)
AU (1) AU2135697A (de)
CA (1) CA2247071C (de)
DE (1) DE69737969T2 (de)
WO (1) WO1997030587A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338890T3 (es) * 1999-03-12 2010-05-13 The Board Of Trustees Of The Leland Stanford Junior University Vacunacion por dna para el tratamiento de enfermedades autoinmunes.
US7030098B2 (en) * 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
US20040131633A1 (en) * 1999-04-21 2004-07-08 University Of Technology, Sydney Parasite antigens
ATE413190T1 (de) * 1999-12-01 2008-11-15 Novartis Vaccines & Diagnostic Hervorrufen von antikörpern spezifisch für hepatitis c virus (hcv)
AUPQ520800A0 (en) * 2000-01-21 2000-02-17 Alfred Hospital Prime-boost vaccination strategy
EP1286664B1 (de) * 2000-05-12 2007-07-25 Oregon Health and Science University Verwendung von niedrigen dosen estrogen in kombination mit immunotherapeutischen verbindungen zur behandlung von immunkrankheiten
US7462486B2 (en) * 2000-05-12 2008-12-09 Oregon Health & Science University Methods of selecting T cell receptor V peptides for therapeutic use
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
JP2004535358A (ja) * 2000-11-02 2004-11-25 パウダージェクト ワクチンズ，インコーポレーテッド 核酸免疫
US20060088546A1 (en) * 2001-04-12 2006-04-27 Riding George A Antigens for raising an immune response against rickettsieae and ehrlichieae pathogens
US20040048822A1 (en) * 2001-11-01 2004-03-11 Juan Harrison Nucleic acid immunization
EP2301553A1 (de) * 2001-11-21 2011-03-30 The Board Of Trustees Of The Leland Stanford Junior University Polynukleotidtherapie
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
US6923958B2 (en) * 2002-03-02 2005-08-02 The Scripps Research Institute DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
US7094410B2 (en) * 2002-03-02 2006-08-22 The Scripps Research Institute DNA vaccine against proliferating endothelial cells and methods of use thereof
JP4750419B2 (ja) 2002-11-21 2011-08-17 ベイヒル セラピューティクス インコーポレーティッド 疾患を予防および治療するための方法および免疫調節核酸組成物
BRPI0415533A (pt) * 2003-10-24 2006-12-26 Immunaid Pty Ltd método de terapia
EP1786465A4 (de) * 2004-07-30 2009-01-21 Univ Oregon Health & Science Verfahren zur detektion und behandlung von autoimmunstörungen
US20080248022A1 (en) * 2004-09-08 2008-10-09 Immunaid Pty Ltd Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
US20060093580A1 (en) * 2004-11-04 2006-05-04 Makio Iwashima Tolerogenic vaccine and method
US20060121031A1 (en) * 2004-12-07 2006-06-08 Mckenzie Brent S Relay vaccine
EP2164862B1 (de) 2007-06-08 2015-07-22 Australian Poultry CRC Pty Ltd Das clostridient-toxin netb
AU2008294074B2 (en) 2007-08-30 2015-01-22 Walter And Eliza Hall Institute Of Medical Research Dendritic cell marker and uses thereof
CN101945666A (zh) * 2007-12-19 2011-01-12 Mivac发展股份公司 治疗自身免疫和过敏性疾病的组合物及方法
ES2548508T3 (es) 2009-05-27 2015-10-19 Biotempus Limited Métodos de tratamiento de enfermedades
RU2578420C2 (ru) 2010-05-10 2016-03-27 Эсенд Байофармасьютикалз Пти Лтд Иммуностимулирующие и вакцинные композиции
SE535625C2 (sv) 2010-10-28 2012-10-16 Toleranzia Ab Nya kompositioner och förfaranden för behandling av autoimmuna och allergiska sjukdomar
AU2012327878A1 (en) 2011-10-28 2014-05-29 Patrys Limited PAT-LM1 epitopes and methods for using same
WO2013160865A1 (en) 2012-04-26 2013-10-31 Toleranzia Ab Immunotolerizing fusion proteins for treatment of multiple sclerosis
WO2016000022A1 (en) 2014-06-30 2016-01-07 Murdoch Childrens Research Institute Helicobacter therapeutic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722738A3 (de) * 1991-01-22 1996-10-23 Immune Response Corp Inc Impfung und Verfahren gegen Krankheiten, die von pathologischen Reaktionen durch spezifischen T-Zellpopulation abstammen

Also Published As

Publication number Publication date
DE69737969T2 (de) 2008-04-24
CA2247071C (en) 2009-05-19
US5939400A (en) 1999-08-17
EP0884947A1 (de) 1998-12-23
EP0884947B1 (de) 2007-08-01
WO1997030587A1 (en) 1997-08-28
CA2247071A1 (en) 1997-08-28
AU2135697A (en) 1997-09-10
JP2000506130A (ja) 2000-05-23
ATE368378T1 (de) 2007-08-15
EP0884947A4 (de) 2002-01-23

Similar Documents

Publication Publication Date Title
DE69737969D1 (de) Dns-impfung zur einleitung einer suppressiven t-zell-antwort
DE69426564D1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
AU637203B2 (en) Power generation system with flat fuel cells of solid electrolyte
DE69739877D1 (de) Neuartige Polymer-Elektrolyt-Membranen zur Verwendung in Direkt-Methanol-Brennstoffzellen
DK0476610T3 (da) Kraftgenereringssystem, der anvender brændselsceller
DE3779615D1 (de) Brennstoffzellenstapel mit enddruckplatten.
WO2000003445A3 (en) Electrode made of flexible graphite composite
DK0972445T3 (da) Kimærisk mus som udtrykker et humant antistof
JPS646308A (en) Composite cable for electricity and light transmission
DK1621208T3 (da) DNA-vaccination til behandling af sutoimmun sygdom
DE59611071D1 (de) Hochenergiebatterie mit mehreren Einzelzellen
EP1154505A4 (de) Brennstoffzelle mit festen polymertypen und deren herstellung
IT7924235A0 (it) Determinazione del grado di incrostazione di una cellula elettrochimica ricoperta con una membrana.
JPS6443973A (en) Solid electrolyte fuel cell electrode
JPS52120610A (en) Power supply for small size sound collector
JPS56102083A (en) Molten-carbonate fuel cell
JPS6430613A (en) Electrode for electroendosmotic dehydration
JPS6452385A (en) Electrolyte plate of molten carbonate fuel cell
Kupriyanova-Ashina et al. Effects of RNase from Bacillus intermedius on the growth of Saccharomyces cerevisiae
JPS52150386A (en) Gas separator
JPS5411289A (en) Culturing of cells
JPS5227209A (en) Pcm group transmission relay system
JPS56109453A (en) Glass mat for lead storage battery
JPS5382157A (en) Companding pcm decoder
SE9900134D0 (sv) A method for introducing substances into cells, and use of said method

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee